Skip to main content

RSV clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for
  • EDP 938 Regimens in Children With RSV

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages up to 36 months

    A 2-part study to evaluate the safety, pharmacokinetics and efficacy of EDP-938 in children with RSV infection.

    Sacramento, California and other locations

  • RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

    “Pass on what's important: You’ll give them love in lots of ways. Could protection from RSV be one of them?”

    open to eligible females ages 0-49

    This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.

    Palo Alto, California and other locations

Last updated: